Oxazole derivatives

US7205325B2 · kind B2 · utility

Assignee

• Hoffmann-La Roche Inc. · US

Inventors

• Birgit Bossenmaier · Hanerau-Hademarschen, DE
• Walter-Gunar Friebe · Mannheim, DE
• Thomas Friess · Planegg, DE
• Bernhard Goller · Penzberg, DE
• Matthias Rueth · Penzberg, DE
• Edgar Voss · Bichl, DE

Key dates

• Filing date: Mar 25, 2004
• Grant date: Apr 17, 2007
• Expiry date: Aug 6, 2025

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D413/14
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The present invention 1 includes compounds of formula (I),and their pharmaceutically acceptable salts. These compounds are useful in the control or prevention of cancer.